Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Times Interest Earned (2016 - 2019)

Fate Therapeutics (FATE) has disclosed Times Interest Earned for 7 consecutive years, with -$53.55 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Times Interest Earned fell 37.55% year-over-year to -$53.55, compared with a TTM value of -$227.93 through Sep 2020, down 322.64%, and an annual FY2019 reading of -$57.49, down 45.33% over the prior year.
  • Times Interest Earned was -$53.55 for Q4 2019 at Fate Therapeutics, up from -$67.8 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $218.64 in Q4 2017 and bottomed at -$67.8 in Q3 2019.
  • Average Times Interest Earned over 5 years is -$21.93, with a median of -$37.48 recorded in 2017.
  • Peak annual rise in Times Interest Earned hit 1039.82% in 2017, while the deepest fall reached 138.57% in 2017.
  • Year by year, Times Interest Earned stood at -$12.21 in 2015, then crashed by 90.59% to -$23.26 in 2016, then surged by 1039.82% to $218.64 in 2017, then tumbled by 117.81% to -$38.93 in 2018, then crashed by 37.55% to -$53.55 in 2019.
  • Business Quant data shows Times Interest Earned for FATE at -$53.55 in Q4 2019, -$67.8 in Q3 2019, and -$58.89 in Q2 2019.